Beirana A, Hernández PM

Language: Spanish
References: 24
Page: 190-194
PDF size: 88.39 Kb.

ABSTRACT

Herpes zoster (shingles) is 1 of the 2 manifestations of the human infection with varicella-zoster virus. Varicella is the primary infection, whereas herpes zoster represents the reactivation. Following resolution of this primary infection, Varicella-Zoster virus becomes latent in the dorsal root ganglia until there is a decrease in cellular immunity that triggers the reactivation of the virus. We report the case of a 4-month-old female patient, with diagnosis of herpes zoster; her treatment and evolution.

REFERENCES

1. Straus SE. Overview: the biology of varicella-zoster virus infection. Ann Neurol 1994; 35 Suppl: S4-8.

2. Brody MB, Moyer D. Varicella-zoster virus infection. The complex prevention-treatment picture. Postgrad Med 1997; 102(1): 187-90, 192-4.

3. Reuler JB, Chang MK. Herpes zoster: epidemiology, clinical features, and management. South Med J 1984; 77(9): 1149-56.

4. Pavan-Langston D. Herpes zoster ophthalmicus. Neurology 1995; 45(12 Suppl 8): S50-1.

5. Sobn AJ, Tranmer PA. Ramsay Hunt syndrome in a patient with human immunodeficiency virus infection. J Am Board Fam Pract 2001; 14(5): 392-4.

6. Kost RG, Straus SE. Postherpetic neuralgia—pathogenesis, treatment, and prevention. N Engl J Med 1996; 335(1): 32-42.

7. Kakourou T, Theodoridou M, Mostrou G et al. Herpes zoster in children. J Am Acad Dermatol 1998; 39(2 Pt 1): 207-10.

8. Cohen BA. Pediatric dermatology. London: Mosby-Wolfe, 1993: 1.10-1.11, 4.5-4.6.

9. Hurwitz S. Clinical pediatric dermatology: A textbook of skin disorders of childhood and adolescence. 2nd ed. Philadelphia: WB Saunders, 1993:324-7.

10. Smith CG, Glaser DA. Herpes zoster in childhood: case report and review of the literature. Pediatr Dermatol 1996; 13(3): 226-9.

11. Latif R, Shope TC. Herpes zoster in normal and immunocompromised children. Am J Dis Child 1983; 137(8): 801-2.

12. Guess HA, Broughton DD, Melton LJ 3rd et al. Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics 1985; 76(4): 512-7.

13. Wiss K. Herpes zoster in healthy children. J Watch Dermatol 1994; 2(1): 4-5.

14. Plotkin SA, Starr SE, Connor K et al. Zoster in normal children after varicella vaccine. (Letter) J Infect Dis 1989; 159(5): 1000-1.

15. Liang MG, Heidelberg KA, Jacobson RM et al. Herpes zoster after varicella immunization. J Am Acad Dermatol 1998; 38(5 Pt 1): 761-3.

16. Straus SE, Oxman MN. Varicella and herpes zoster. In: Freedberg IM, Eisen AZ, Wolff K et al. Fitzpatrick’s dermatology in general medicine. 5th ed. New York: McGraw-Hill, 1999; 2: 2427-50.

17. Tyring S, Barbarash RA, Nahlik JE et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 1995; 123(2): 89-96.

18. Wood MJ. Current experience with antiviral therapy for acute herpes zoster. Ann Neurol 1994; 35 Suppl: S65-8.

19. Whitley RJ, Weiss H, Gnann JW et al. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med 1996; 125(5): 376-83.

20. Wood MJ, Johnson RW, McKendrick MW et al. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994; 330(13): 896-900.

21. Tyring SK, Beutner KR, Tucker BA et al. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 2000; 9(9): 863-9.

22. Nikkels AF, Pierard GE. Recognition and treatment of shingles. Drugs 1994; 48(4): 528-48.

23. Oxman MN, Levin MJ, Johnson GR et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352(22): 2271-84.

24. Vazquez M, Shapiro ED. Varicella vaccine and infection with varicella-zoster virus. N Engl J Med 2005; 352(5): 439-40.